Invitae

$38.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.51 (+1.36%) As of 3:38 PM UTC today

Why Robinhood?

You can buy or sell Invitae and other stocks, options, and ETFs commission-free!

About NVTA

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases.

CEO
Sean Emerson George, PhD
Employees
2,100
Headquarters
San Francisco, California
Founded
2010
Market Cap
7.09B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.57M
High Today
$39.50
Low Today
$37.64
Open Price
$37.73
Volume
1.15M
52 Week High
$61.59
52 Week Low
$12.42

NVTA Earnings

-$0.80
-$0.53
-$0.27
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 4, After Hours

You May Also Like

NSC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure